Investigating the Effects of Olaparib on the Susceptibility of Glioblastoma Multiforme Tumour Cells to Natural Killer Cell-Mediated Responses

Glioblastoma multiforme (GBM) is the most common adult primary brain malignancy, with dismal survival rates of ~14.6 months. The current standard-of-care consists of surgical resection and chemoradiotherapy, however the treatment response is limited by factors such as tumour heterogeneity, treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Moran, Jennifer, Mylod, Eimear, Kane, Laura E., Marion, Caroline, Keenan, Emily, Mekhaeil, Marianna, Lysaght, Joanne, Dev, Kumlesh K., O’Sullivan, Jacintha, Conroy, Melissa J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959685/
https://www.ncbi.nlm.nih.gov/pubmed/36839682
http://dx.doi.org/10.3390/pharmaceutics15020360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959685/
https://www.ncbi.nlm.nih.gov/pubmed/36839682
http://dx.doi.org/10.3390/pharmaceutics15020360

Ejemplares similares